Aegros set to move on to CSL’s plasma turf
MELBOURNE: It’s been a 30-plus year journey for small plasma fractionation biotech Aegros, ... read more
Priceline operator API reports 30% drop in profit
MELBOURNE: Priceline operator Australian Pharmaceutical Industries is hopeful about the future of its ... read more